Inotiv Inc (NOTV)
1.76
+0.04
(+2.33%)
USD |
NASDAQ |
Jun 14, 16:00
1.74
-0.02
(-1.14%)
After-Hours: 20:00
Inotiv Free Cash Flow: 9.573M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 9.573M |
December 31, 2023 | 4.042M |
September 30, 2023 | 0.38M |
June 30, 2023 | -17.06M |
March 31, 2023 | -41.76M |
December 31, 2022 | -50.50M |
September 30, 2022 | -41.52M |
June 30, 2022 | -38.08M |
March 31, 2022 | -15.00M |
December 31, 2021 | -8.702M |
September 30, 2021 | -1.726M |
June 30, 2021 | -1.711M |
March 31, 2021 | 0.194M |
December 31, 2020 | -4.019M |
September 30, 2020 | -4.91M |
June 30, 2020 | -5.646M |
March 31, 2020 | -6.799M |
December 31, 2019 | -6.037M |
September 30, 2019 | -5.101M |
June 30, 2019 | -2.077M |
March 31, 2019 | 0.454M |
December 31, 2018 | 1.808M |
September 30, 2018 | 2.17M |
June 30, 2018 | 1.136M |
March 31, 2018 | 0.895M |
Date | Value |
---|---|
December 31, 2017 | 0.57M |
September 30, 2017 | 0.889M |
June 30, 2017 | 1.408M |
March 31, 2017 | 0.713M |
December 31, 2016 | 1.222M |
September 30, 2016 | -0.196M |
June 30, 2016 | -0.439M |
March 31, 2016 | -0.078M |
December 31, 2015 | 0.406M |
September 30, 2015 | 0.637M |
June 30, 2015 | 0.831M |
March 31, 2015 | 0.548M |
December 31, 2014 | -0.074M |
September 30, 2014 | 1.194M |
June 30, 2014 | 1.055M |
March 31, 2014 | 1.95M |
December 31, 2013 | 1.864M |
September 30, 2013 | 1.586M |
June 30, 2013 | 1.53M |
March 31, 2013 | 0.379M |
December 31, 2012 | -0.461M |
September 30, 2012 | -1.29M |
June 30, 2012 | -2.566M |
March 31, 2012 | -2.697M |
December 31, 2011 | -0.634M |
Free Cash Flow Range, Past 5 Years
-50.50M
Minimum
Dec 2022
9.573M
Maximum
Mar 2024
-11.82M
Average
-5.374M
Median
Free Cash Flow Benchmarks
Biolase Inc | -14.37M |
Akoya Biosciences Inc | -55.62M |
Durect Corp | -31.92M |
Macrogenics Inc | -113.88M |
Candel Therapeutics Inc | -32.19M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 16.92M |
Cash from Investing (Quarterly) | -4.587M |
Cash from Financing (Quarterly) | -1.173M |
Free Cash Flow Per Share (Quarterly) | 0.3831 |
Free Cash Flow to Equity (Quarterly) | 8.605M |
Free Cash Flow to Firm (Quarterly) | 19.69M |
Free Cash Flow Yield | 21.10% |